EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial

Reem Elhaddad Ali, Mohammed Abu El-Hamd, Amr Abdelhamed, Mohamad AlaaEldein Elsuity, Ramadan Saleh

Dermatology Practical & Conceptual · 30.04.2026 · 16 (2) · 6129

DOI: 10.5826/dpc.1602a6129 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.04.2026. Verfasst von Reem Elhaddad Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Venereology and Andrology Department, Faculty of Medicine, Sohag University, Sohag, Egypt. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Emerging evidence suggests that platelet-rich plasma (PRP) has an antifungal role.

Objectives

To investigate the efficacy of intralesional PRP in the treatment of fingernail onychomycosis. Patients and Methods: Patients with fingernail onychomycosis were randomized to receive oral terbinafine 250 mg daily for three months, six sessions of intralesional PRP, or both (PRP + terbinafine). Primary outcome of the study was change in onychomycosis severity index (OSI) at the end of follow-up. Two blinded investigators (investigators A and B) assessed the outcomes. The assessment was carried out per affected nail rather than per affected patient.

Results

Twenty, 18, and 23 patients were included in the terbinafine, PRP, and terbinafine + PRP groups, respectively, with 40, 51, and 50 nails treated in each respective group. OSI was comparable among study groups according to investigator A (terbinafine: 4 [IQRs: 4, 9], PRP: 6 [IQRs: 2, 12], PRP + terbinafine: 5 [IQRs: 3, 8]; p>0.9) and investigator B (terbinafine: 4 [IQRs: 3, 10], PRP: 6 [IQRs: 4, 10], PRP + terbinafine: 6 [IQRs: 3, 12]; P>0.9). Similarly, mycological cure (terbinafine: 20%, PRP: 35%, PRP + terbinafine: 34%; P=0.23), clinical cure (terbinafine: 23%, PRP: 27%, PRP + terbinafine: 32%; P=0.61), and complete cure (terbinafine: 20%, PRP: 27%, PRP + terbinafine: 28%; P=0.64) were comparable.

Conclusions

Six sessions of intralesional PRP were effective in treating fingernail onychomycosis, making it a potential viable alternative for patients who may not respond well to oral antifungal medications or who experience adverse effects from these drugs.

Autor:innen und Institutionen

  • Dermatology, Venereology and Andrology Department, Faculty of Medicine, Sohag University, Sohag, Egypt.

Zitieren

APA

Ali, R. E., El-Hamd, M. A., Abdelhamed, A., Elsuity, M. A., & Saleh, R. (2026). Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial. Dermatology Practical & Conceptual, 16(2), 6129. https://doi.org/10.5826/dpc.1602a6129

Vancouver

Ali RE, El-Hamd MA, Abdelhamed A, Elsuity MA, Saleh R. Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial. Dermatology Practical & Conceptual. 2026;16(2):6129. doi:10.5826/dpc.1602a6129

BibTeX
@article{Ali2026,
  author = {Ali, Reem Elhaddad and El-Hamd, Mohammed Abu and Abdelhamed, Amr and Elsuity, Mohamad AlaaEldein and Saleh, Ramadan},
  title = {Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial},
  journal = {Dermatology Practical & Conceptual},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {6129},
  doi = {10.5826/dpc.1602a6129}
}
Kostenlos starten →